Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price target of €174.00. The company’s shares closed ...

In this article, we are going to take a look at where Merck KGaA (OTC:MKGAF) stands against Morgan Stanley's other European AI stocks. In August last year, investment bank Morgan Stanley released ...

Merck KGaA and Pfizer have got the fourth checkpoint inhibitor to market after the US regulator approved their avelumab for a rare form of skin cancer. The FDA’s approval of avelumab ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

To find out more about Merck Serono and its parent company, take a look at "A history of Merck KGaA".

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

(RTTNews) - Drug major Merck & Co. (MRK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP recommended the approval of CAPVAXIVE ...

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical ...

KWS SAAT SE KGaA (ETR:KWS) has had a rough three months with its share price down 4.3%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals ...

Research reports are not currently available for 1MRK.MI.